Mubadala Invests in Manipal Health Enterprises to Enhance Healthcare in India
Mubadala Investment Company in Abu Dhabi, United Arab Emirates, announced today its investment in India’s Manipal Health Enterprises (Manipal), reaffirming its commitment to developing the healthcare sector in India. This deal aims to enhance the provision of high-quality healthcare services at affordable prices for patients in India.
Manipal is one of the leading healthcare networks in India, offering its services through a multi-specialty network that includes more than 30 hospitals serving around 6 million patients annually. Manipal is considered the second-largest hospital chain in India in terms of bed count, housing more than 5,000 doctors.
Camilla McKabely Lanquili, Head of Life Sciences at Mubadala, expressed her eagerness to support Manipal in its growth journey and development in the coming years. These investments are an important step towards improving healthcare services in India and meeting the increasing demand for high-quality medical care.
On his part, Luca Molinari, Head of Direct Investments in Asia at Mubadala, emphasized the importance of partnering with distinguished partners such as Temasek, TPG, Dr. Ranjan Pai, and the executive team at Manipal to enhance the growth path and develop healthcare infrastructure in India.
Founded in 1991 by Dr. Ranjan Pai, Manipal has since successfully expanded its operations rapidly to cover various regions of India. This step in the healthcare investment world is a positive move to enhance healthcare in India and improve the quality of services provided to patients.
